We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Measuring Blood Pressure in Pregnancy Using Mercury and Automated Device (PRAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00809666
Recruitment Status : Completed
First Posted : December 17, 2008
Last Update Posted : December 17, 2008
Sponsor:
Information provided by:
St George Hospital, Australia

Brief Summary:
The aim of the PRAM study was to determine whether women diagnosed with hypertension in pregnancy, using the traditional mercury device, have the same pregnancy outcomes when blood pressure is measured by either an automated device or a mercury device throughout the pregnancy.

Condition or disease Intervention/treatment
Hypertension Pregnancy Pre Eclampsia Device: Automated blood pressure recording device Omron HEM 705CP

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 220 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Diagnostic
Official Title: A Prospective Randomised Study of Automated Versus Mercury Blood Pressure Recordings in Pregnancy
Study Start Date : May 2000
Primary Completion Date : September 2006
Study Completion Date : September 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Mercury
U.S. FDA Resources

Arm Intervention/treatment
No Intervention: Mercury
All subsequent blood pressure recording done using mercury sphygmomanometry
Device: Automated blood pressure recording device Omron HEM 705CP
All subsequent blood pressure recordings done using the automated device



Primary Outcome Measures :
  1. The primary maternal outcome measure was the number of women having any episode of severe hypertension (BP ³ 170/110mmHg).

Secondary Outcome Measures :
  1. Secondary end points included gestation at birth, caesarean section and induction of labour rates.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years to 45 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • women with a diagnosis of hypertension in pregnancy

Exclusion Criteria:

  • non-pregnant and normotensive pregnancy women

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00809666


Locations
Australia, New South Wales
St George Hospital
Sydney, New South Wales, Australia, 2217
Sponsors and Collaborators
St George Hospital, Australia

Publications:
High blood pressure research Council of Australia. Position Statement on the replacement of mercury sphygmomanometers. September 2006. www.hbprca.com.au

Responsible Party: Professor Mark Brown, St George Hospital and UNSW
ClinicalTrials.gov Identifier: NCT00809666     History of Changes
Other Study ID Numbers: 00/41 Brown
First Posted: December 17, 2008    Key Record Dates
Last Update Posted: December 17, 2008
Last Verified: December 2008

Keywords provided by St George Hospital, Australia:
pregnancy
hypertension
mercury sphygmomanometry
blood pressure
automated blood pressure
pre eclampsia
Hypertension in pregnancy

Additional relevant MeSH terms:
Hypertension
Eclampsia
Pre-Eclampsia
Vascular Diseases
Cardiovascular Diseases
Hypertension, Pregnancy-Induced
Pregnancy Complications